Literature DB >> 1877105

Management of renal cell carcinoma with vena caval thrombi via cardiopulmonary bypass and deep hypothermic circulatory arrest.

E A Klein1, M C Kaye, A C Novick.   

Abstract

Cardiopulmonary bypass with deep hypothermic circulatory arrest allows safe and effective removal of renal tumors with extensive thrombi involving the vena cava under controlled circumstances without permanent side effects. The technique averts extensive dissection of the inferior vena cava and occlusion of major vessels while providing up to 60 minutes of safe operating time in a bloodless field and complete visibility of the interior of the vena cava. Adjunctive procedures for tumor excision or cardiac revascularization can be performed at the same time without increased operative risk.

Entities:  

Mesh:

Year:  1991        PMID: 1877105

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  4 in total

1.  Clinical outcomes related to the level of clamping in inferior vena cava surgery.

Authors:  Heungman Jun; Youngjin Han; Hojong Park; Sung Shin; Yong-Pil Cho; Tae-Won Kwon
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

2.  Use of veno-venous bypass for resection of malignant pheochromocytoma with vena caval thrombus.

Authors:  Raphaela Waidelich; Ernst Weninger; Claudio Denzlinger; Ulrike Müller-Lisse; Alfons Hofstetter; Nikolaus Schmeller
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

3.  Benefits of liver transplantation surgical techniques in the management of extensive retroperitoneal tumors.

Authors:  Marcelo E Facciuto; Manoj K Singh; Juan P Rocca; Caroline Rochon; Manuel I Rodriguez Davalos; Majid Eshghi; David M Schwalb; Muhammad Choudhury; Patricia A Sheiner
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

4.  Transabdominal approach for renal cell carcinoma with supradiaphragmatic tumor thrombus: description of a modified technique and indications for treatment.

Authors:  Guoliang Wang; Hai Bi; Jianfei Ye; Hongxian Zhang; Xiaofei Hou; Cheng Liu; Min Qiu; Yu Tian; Dharam Kaushik; Lulin Ma
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.